Teacher Retirement System of Texas Cuts Stock Holdings in Avanos Medical, Inc. (NYSE:AVNS)

Teacher Retirement System of Texas lessened its stake in Avanos Medical, Inc. (NYSE:AVNS) by 47.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 62,871 shares of the company’s stock after selling 56,422 shares during the period. Teacher Retirement System of Texas owned about 0.14% of Avanos Medical worth $1,001,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the stock. Quarry LP bought a new stake in Avanos Medical in the third quarter valued at approximately $42,000. Intech Investment Management LLC purchased a new stake in Avanos Medical during the 3rd quarter valued at $207,000. Atom Investors LP bought a new stake in Avanos Medical in the 3rd quarter worth $210,000. EP Wealth Advisors LLC purchased a new position in shares of Avanos Medical in the third quarter valued at about $212,000. Finally, US Bancorp DE raised its stake in shares of Avanos Medical by 18.0% during the fourth quarter. US Bancorp DE now owns 14,093 shares of the company’s stock valued at $224,000 after acquiring an additional 2,147 shares during the last quarter. 95.17% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, SVP Kerr Holbrook sold 7,000 shares of the business’s stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $15.25, for a total value of $106,750.00. Following the completion of the transaction, the senior vice president now directly owns 82,047 shares in the company, valued at $1,251,216.75. The trade was a 7.86 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 2.64% of the company’s stock.

Avanos Medical Price Performance

Shares of Avanos Medical stock opened at $13.96 on Friday. The business has a 50 day moving average of $15.66 and a 200 day moving average of $18.34. Avanos Medical, Inc. has a 52 week low of $13.87 and a 52 week high of $25.36. The company has a market cap of $641.97 million, a PE ratio of 41.04 and a beta of 1.17. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12.

Avanos Medical (NYSE:AVNS) last released its earnings results on Wednesday, February 26th. The company reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.03. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. The firm had revenue of $179.60 million during the quarter, compared to analyst estimates of $177.23 million. As a group, equities research analysts forecast that Avanos Medical, Inc. will post 1.32 earnings per share for the current year.

Analyst Ratings Changes

Separately, StockNews.com raised Avanos Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, March 19th.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.